162 related articles for article (PubMed ID: 38069178)
21. Ameliorative effect of phosphodiesterase 4 and 5 inhibitors in deoxycorticosterone acetate-salt hypertensive uni-nephrectomized KKA
Nio Y; Ookawara M; Yamasaki M; Hanauer G; Tohyama K; Shibata S; Sano T; Shimizu F; Anayama H; Hazama M; Matsuo T
FASEB J; 2020 Nov; 34(11):14997-15014. PubMed ID: 32939821
[TBL] [Abstract][Full Text] [Related]
22. Impact of salt on cardiac differential gene expression and coronary lesion in normotensive mineralocorticoid-treated mice.
Wang Q; Domenighetti AA; Schäfer SC; Weber J; Simon A; Maillard MP; Pedrazzini T; Chen J; Lehr HA; Burnier M
Am J Physiol Regul Integr Comp Physiol; 2012 May; 302(9):R1025-33. PubMed ID: 22403797
[TBL] [Abstract][Full Text] [Related]
23. Triptolide attenuates renal damage by limiting inflammatory responses in DOCA-salt hypertension.
Zhang J; Zhu M; Zhang S; Xie S; Gao Y; Wang Y
Int Immunopharmacol; 2020 Dec; 89(Pt A):107035. PubMed ID: 33045566
[TBL] [Abstract][Full Text] [Related]
24. Tranilast attenuates myocardial fibrosis in association with suppression of monocyte/macrophage infiltration in DOCA/salt hypertensive rats.
Kagitani S; Ueno H; Hirade S; Takahashi T; Takata M; Inoue H
J Hypertens; 2004 May; 22(5):1007-15. PubMed ID: 15097242
[TBL] [Abstract][Full Text] [Related]
25. Role of the monocyte chemoattractant protein-1/C-C chemokine receptor 2 signaling pathway in transient receptor potential vanilloid type 1 ablation-induced renal injury in salt-sensitive hypertension.
Wang Y; Zhu M; Xu H; Cui L; Liu W; Wang X; Shen S; Wang DH
Exp Biol Med (Maywood); 2015 Sep; 240(9):1223-34. PubMed ID: 25585624
[TBL] [Abstract][Full Text] [Related]
26. Curative effect of sesame oil in a rat model of chronic kidney disease.
Liu CT; Chien SP; Hsu DZ; Periasamy S; Liu MY
Nephrology (Carlton); 2015 Dec; 20(12):922-30. PubMed ID: 26016645
[TBL] [Abstract][Full Text] [Related]
27. Secreted protein acidic and rich in cysteine (SPARC) and a disintegrin and metalloproteinase with thrombospondin type 1 motif (ADAMTS1) increments by the renin-angiotensin system induce renal fibrosis in deoxycorticosterone acetate-salt hypertensive rats.
Toba H; Ikemoto MJ; Kobara M; Nakata T
Eur J Pharmacol; 2022 Jan; 914():174681. PubMed ID: 34871556
[TBL] [Abstract][Full Text] [Related]
28. Endothelin receptor blockade ameliorates renal injury by inhibition of RhoA/Rho-kinase signalling in deoxycorticosterone acetate-salt hypertensive rats.
Lee TM; Chung TH; Lin SZ; Chang NC
J Hypertens; 2014 Apr; 32(4):795-805. PubMed ID: 24463935
[TBL] [Abstract][Full Text] [Related]
29. Kallikrein gene transfer reduces renal fibrosis, hypertrophy, and proliferation in DOCA-salt hypertensive rats.
Xia CF; Bledsoe G; Chao L; Chao J
Am J Physiol Renal Physiol; 2005 Sep; 289(3):F622-31. PubMed ID: 15886273
[TBL] [Abstract][Full Text] [Related]
30. Role of angiotensin II in renal injury of deoxycorticosterone acetate-salt hypertensive rats.
Kim S; Ohta K; Hamaguchi A; Omura T; Yukimura T; Miura K; Inada Y; Wada T; Ishimura Y; Chatani F
Hypertension; 1994 Aug; 24(2):195-204. PubMed ID: 8039844
[TBL] [Abstract][Full Text] [Related]
31. Fibroblast Growth Factor 23 Exacerbates Cardiac Fibrosis in Deoxycorticosterone Acetate-Salt Mice With Hypertension.
Saito T; Mizobuchi M; Kato T; Ogata H; Koiwa F; Honda H
Lab Invest; 2023 Jan; 103(1):100003. PubMed ID: 36748187
[TBL] [Abstract][Full Text] [Related]
32. Heme arginate therapy enhanced adiponectin and atrial natriuretic peptide, but abated endothelin-1 with attenuation of kidney histopathological lesions in mineralocorticoid-induced hypertension.
Ndisang JF; Jadhav A
J Pharmacol Exp Ther; 2010 Jul; 334(1):87-98. PubMed ID: 20392817
[TBL] [Abstract][Full Text] [Related]
33. Obesity induced renal oxidative stress contributes to renal injury in salt-sensitive hypertension.
Quigley JE; Elmarakby AA; Knight SF; Manhiani MM; Stepp DW; Olearzcyk JJ; Imig JD
Clin Exp Pharmacol Physiol; 2009 Jul; 36(7):724-8. PubMed ID: 19207724
[TBL] [Abstract][Full Text] [Related]
34. COX-2-independent activation of renal (pro)renin receptor contributes to DOCA-salt hypertension in rats.
Wang F; Sun Y; Luo R; Lu X; Yang B; Yang T
Am J Physiol Renal Physiol; 2020 Oct; 319(4):F647-F653. PubMed ID: 32799674
[TBL] [Abstract][Full Text] [Related]
35. Detrimental role of sphingosine kinase 1 in kidney damage in DOCA-salt hypertensive model: evidence from knockout mice.
Lyu B; Wang W; Ji XY; Ritter JK; Li N
BMC Nephrol; 2020 May; 21(1):173. PubMed ID: 32393187
[TBL] [Abstract][Full Text] [Related]
36. Fibroblast growth factor 21 attenuates salt-sensitive hypertension-induced nephropathy through anti-inflammation and anti-oxidation mechanism.
Weng HC; Lu XY; Xu YP; Wang YH; Wang D; Feng YL; Chi Z; Yan XQ; Lu CS; Wang HW
Mol Med; 2021 Nov; 27(1):147. PubMed ID: 34773993
[TBL] [Abstract][Full Text] [Related]
37. Myocardial fibrosis in DOCA-salt hypertensive rats: effect of endothelin ET(A) receptor antagonism.
Ammarguellat F; Larouche I; Schiffrin EL
Circulation; 2001 Jan; 103(2):319-24. PubMed ID: 11208696
[TBL] [Abstract][Full Text] [Related]
38. TNF-alpha inhibition reduces renal injury in DOCA-salt hypertensive rats.
Elmarakby AA; Quigley JE; Imig JD; Pollock JS; Pollock DM
Am J Physiol Regul Integr Comp Physiol; 2008 Jan; 294(1):R76-83. PubMed ID: 17989143
[TBL] [Abstract][Full Text] [Related]
39. Dietary chloride does not correlate with urinary thromboxane in deoxycorticosterone acetate-treated rats.
Theriot JA; Passmore JC; Jimenez AE; Fleming JT
J Lab Clin Med; 2000 Jun; 135(6):493-7. PubMed ID: 10850649
[TBL] [Abstract][Full Text] [Related]
40. Cortical and medullary hemodynamics in deoxycorticosterone acetate-salt hypertensive mice.
Gross V; Lippoldt A; Bohlender J; Bader M; Hansson A; Luft FC
J Am Soc Nephrol; 1998 Mar; 9(3):346-54. PubMed ID: 9513896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
